Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Volcano Corporation highlight its new product launches  presence in live cases, and participation in late breaking trials during EuroPCR.

Volcano Corporation announced the participation  in the Annual Scientific Sessions of the American College of Cardiology (ACC) Conference from March 14th to March 16th in Atlanta, GA.

Volcano Corporation said that revenues for the quarter ended December 31, 2009, were $71.0 million, an increase of 44 percent versus revenues of $49.3 million in the fourth quarter a year ago.

Volcano Corporation received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Eagle Eye Platinum digital IVUS catheter in the United States.

Volcano Corporation announced receipt of CE mark for their OCT (Optical Coherence Tomography) imaging system and catheter.

Volcano Corporation announced Placement of Over 2,500 s5 and s5i Multi-Modality Systems Highlights Continued Momentum versus Competition, Growing World-Wide Demand for Access to FFR and IVUS

Axsun Technologies, Inc., announced the initial development and successful testing of a novel integrated light source architecture for OCT imaging.

Volcano Corporation announces that it will be attending in the Third Annual Canaccord Cardiovascular Conference on November 10.